|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01833 PA GOODDOCTOR
Nominal 
11.930 +0.170 (+1.446%) Ranking Overview
Ranking based on 9 research report(s)
Average Ranking 2.67
|
Strong Buy (1)
0
|
Buy (2)
4
|
Hold (3)
4
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 18.00 RMB (cts) | |
| Net Profit | 379.51 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 456.00 | 22.00 | 0 | -- | 644.00 | 350.00 |
| 2027 | 609.55 | 30.00 | 0 | -- | 853.00 | 487.00 |
| 2028 | 957.50 | 45.20 | 0 | -- | 1,100.20 | 844.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 395.00 | 18.00 | -- | CITIC SEC | Buy | 21.00 | 25/11/2025 | |
| 2026 | 644.00 | 30.00 | -- | CLSA | OutPerform | 19.00 | 26/03/2026 | |
| 2026 | 456.00 | 22.10 | -- | CITIGROUP | Buy | 18.00 | 25/03/2026 | |
| 2026 | 550.50 | 28.20 | -- | UOB | Buy | 17.50 | 26/03/2026 | |
| 2026 | 390.00 | 18.00 | -- | MORGAN STANLEY | Equal-weight | 16.30 | 23/10/2025 | |
| 2026 | 478.00 | 22.00 | -- | UBS | Neutral | 14.50 | 25/03/2026 | |
| 2026 | 414.00 | 20.00 | -- | SPDB INT'L SEC | Hold | 14.00 | 28/10/2025 | |
| 2026 | 490.77 | 24.00 | -- | JEFFERIES HK | Hold | 12.40 | 25/03/2026 | |
| 2026 | 350.00 | 16.70 | -- | BANK OF AMERICA | UnderPerform | 8.30 | 13/03/2026 | |
| 2027 | 539.00 | 25.00 | -- | CITIC SEC | -- | -- | 25/11/2025 | |
| 2027 | 853.00 | 39.00 | -- | CLSA | -- | -- | 26/03/2026 | |
| 2027 | 659.00 | 31.90 | -- | CITIGROUP | -- | -- | 25/03/2026 | |
| 2027 | 805.40 | 40.60 | -- | UOB | -- | -- | 26/03/2026 | |
| 2027 | 507.00 | 23.00 | -- | MORGAN STANLEY | -- | -- | 23/10/2025 | |
| 2027 | 663.00 | 31.00 | -- | UBS | -- | -- | 25/03/2026 | |
| 2027 | 569.00 | 20.00 | -- | SPDB INT'L SEC | -- | -- | 28/10/2025 | |
| 2027 | 609.55 | 30.00 | -- | JEFFERIES HK | -- | -- | 25/03/2026 | |
| 2027 | 487.00 | 23.00 | -- | BANK OF AMERICA | -- | -- | 13/03/2026 | |
| 2028 | 1,000.00 | 46.00 | -- | CLSA | -- | -- | 26/03/2026 | |
| 2028 | 915.00 | 44.40 | -- | CITIGROUP | -- | -- | 25/03/2026 | |
| 2028 | 1,100.20 | 55.10 | -- | UOB | -- | -- | 26/03/2026 | |
| 2028 | 844.00 | 39.00 | -- | UBS | -- | -- | 25/03/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 27/03/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 379,511 |
| %Change | 366.069% |
| EPS / (LPS) | RMB 0.180 |
| NBV Per Share (¥) | RMB 4.588 |